Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
The RSV Type A Glycoprotein G gene, also known as RSV G protein, is a target for developing vaccines and antiviral therapies against respiratory syncytial virus (RSV). RSV is a highly contagious virus that causes respiratory tract infections, especially in infants and young children. The G protein is a major surface antigen of RSV that plays a crucial role in virus attachment and fusion with host cells. The G protein has two antigenic sites, A and B, that are important for inducing neutralizing antibodies. Targeting the G protein can potentially prevent RSV infection and reduce the severity of respiratory disease.
仅用于科研。不用于诊断过程。未经明确授权不得转售。